Editorial: Interleukin-7 and Its Receptor: The Axis of Evil to Target in Sjogren's Syndrome?

被引：7
|
作者：
van Roon, Joel A. G. [1 ]
Kruize, Aike A. [1 ]
Radstake, Timothy R. D. J. [1 ]
机构：
[1] Univ Med Ctr Utrecht, Utrecht, Netherlands
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷 / 08期
关键词：
SALIVARY-GLANDS; T-CELLS; EXPRESSION; TH1;
D O I：
10.1002/art.38002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1980 / 1984
页数：5
相关论文
共 50 条
  • [41] Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias
    Shochat, Chen
    Tal, Noa
    Bandapalli, Obul R.
    Palmi, Chiara
    Ganmore, Ithamar
    Kronnie, Geertruy Te
    Cario, Gunnar
    Cazzaniga, Giovanni
    Kulozik, Andreas E.
    Stanulla, Martin
    Schrappe, Martin
    Biondi, Andrea
    Basso, Giuseppe
    Bercovich, Dani
    Muckenthaler, Martina U.
    Izraeli, Shai
    JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 208 (05): : 901 - 908
  • [42] Mapping autophagosome contents identifies interleukin-7 receptor-α as a key cargo modulating CD4+T cell proliferation
    Zhou, Dingxi
    Borsa, Mariana
    Puleston, Daniel J.
    Zellner, Susanne
    Capera, Jesusa
    Sanderson, Sharon
    Schifferer, Martina
    Hester, Svenja S.
    Ge, Xin
    Fischer, Roman
    Jostins, Luke
    Behrends, Christian
    Alsaleh, Ghada
    Simon, Anna Katharina
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [43] The P2X7 receptor-inflammasome complex has a role in modulating the inflammatory response in primary Sjogren's syndrome
    Baldini, C.
    Rossi, C.
    Ferro, F.
    Santini, E.
    Seccia, V.
    Donati, V.
    Solini, A.
    JOURNAL OF INTERNAL MEDICINE, 2013, 274 (05) : 480 - 489
  • [44] Research Note: Development and characterization of monoclonal antibodies specific for chicken interleukin-7 receptor α (CD127)
    Sun, Zhifeng
    Lu, Mingmin
    Kim, Woohyun
    Lillehoj, Hyun
    Panebra, Alfredo
    Zhao, Hongyan
    Li, Charles
    POULTRY SCIENCE, 2022, 101 (10)
  • [45] TLR7 Signaling Drives the Development of Sjogren's Syndrome
    Wang, Yawen
    Roussel-Queval, Annie
    Chasson, Lionel
    Hanna Kazazian, Noel
    Marcadet, Laetitia
    Nezos, Andrianos
    Sieweke, Michael H.
    Mavragani, Clio
    Alexopoulou, Lena
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [46] Serum interleukin-17 in primary Sjogren's syndrome: association with disease duration and parotid gland swelling
    Alunno, A.
    Bistoni, O.
    Caterbi, S.
    Bartoloni, E.
    Cafaro, G.
    Gerli, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (01) : 129 - 129
  • [47] Interleukin-12 exacerbates Sjogren's syndrome through induction of myeloid-derived suppressor cells
    Qi, Jingjing
    Li, Dan
    Shi, Guoping
    Zhang, Xuefang
    Pan, Yuchen
    Dou, Huan
    Wang, Tingting
    Yao, Genhong
    Hou, Yayi
    MOLECULAR MEDICINE REPORTS, 2019, 20 (02) : 1131 - 1138
  • [48] Interleukin-7 receptor blockade by an anti-CD127 monoclonal antibody in nonhuman primate kidney transplantation
    Hoa Le Mai
    Thi Van Ha Nguyen
    Branchereau, Julien
    Poirier, Nicolas
    Renaudin, Karine
    Mary, Caroline
    Belarif, Lyssia
    Minault, David
    Hervouet, Jeremy
    Le Bas-Berdardet, Stephanie
    Soulillou, Jean-Paul
    Vanhove, Bernard
    Blancho, Gilles
    Brouard, Sophie
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 (01) : 101 - 111
  • [49] High soluble IL-7 receptor expression in Sjogren's syndrome identifies patients with increased immunopathology and dryness
    Hillen, M. R.
    Blokland, S. L. M.
    Risselada, A. P.
    Bikker, A.
    Lauwerys, B. R.
    Kruize, A. A.
    Radstake, T. R. D. J.
    van Roon, J. A. G.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (09) : 1735 - 1736
  • [50] Activation of Toll-like receptor 7 signaling in labial salivary glands of primary Sjogren's syndrome patients
    Shimizu, T.
    Nakamura, H.
    Takatani, A.
    Umeda, M.
    Horai, Y.
    Kurushima, S.
    Michitsuji, T.
    Nakashima, Y.
    Kawakami, A.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2019, 196 (01): : 39 - 51
12345